Skip to main content
ConductScienceScienceDex

Remi Adelaiye-Ogala

From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.

FY2026 NIH rank #17,191
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 77926996Search this ID in NIH RePORTER
ORCID iD
https://orcid.org/0000-0002-6581-7359Verified identifier for this researcher
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine

NIH Funding · FY2026

Linked Award Amount
$1.1M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#17,191
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Remi Adelaiye-Ogala. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$1.1M

2 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Remi Adelaiye-Ogala as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA290402-03R01Contact PI
    Posttranslational modifications of glucocorticoid receptor associated with drug-resistance in prostate cancer
    University at Buffalo · Internal Medicine (NIH department code)
    $619.1K
    award amount
  • 5R37CA272726-04R37Contact PI
    Therapeutic targeting of master regulators in non-canonical AR driven advanced lethal prostate cancers
    University at Buffalo · Internal Medicine (NIH department code)
    $526.5K
    award amount

Award organization

Organizations that administered FY2026 awards listing Remi Adelaiye-Ogala as a PI.

FY2026 award administered by University at Buffalo (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University at Buffalo
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    R01 Grant Holder

Explore further

Find collaborators for Remi Adelaiye-Ogala

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →